期刊文献+

大剂量环磷酰胺治疗重型再生障碍性贫血3例并文献复习 被引量:2

下载PDF
导出
摘要 目的探讨以大剂量环磷酰胺(HDCTX)治疗重型再生障碍性贫血(SAA)的可行性。方法对3例SAA患者行HDCTX免疫抑制剂治疗,观察其疗效及不良反应,并复习相关文献。结果 SAA患者接受HDCTX治疗结束后,1例完全缓解,1例部分缓解,1例死亡。未见明显不良反应。随访至今(53.5个月)未见复发及继发克隆性疾病。结论 HDCTX可能是治疗SAA的有效方法。
出处 《山东医药》 CAS 2013年第36期41-44,共4页 Shandong Medical Journal
基金 山东省医药卫生科技发展计划面上资助项目(2009HZ0010)
  • 相关文献

参考文献18

  • 1Brodsky RA, Sensenbrenner LL, Smith D, et al. Durable treatment- free remission after high-dose cyelophosphamide therapy for previ- ously untreated severe aplastic anemia[J]. Ann Intern Med, 2001, 135(7) :477-483.
  • 2Young NS, Calado RT, Scheinberg P. Current concepts in the pathophysiology and treatment of aplastie anemia[ J ]. Blood, 2006, 108(8) :2509-2519.
  • 3Rosenfeld S, FoUmann D, Nunez O, et al. Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between he- matologic response and long-term outcome [ J ]. JAMA, 2003,289 (9) :1130-1135.
  • 4Seheinberg P, Nunez O, anaemia with combined Wu C, et al. Treat-ment of severe aplastic : anti-thymocyte globu- lin, ciclosporin and mycophenolate mofetil [ J ]. Br J Haematol, 2006,133(6) :606-611.
  • 5Viollier R, Passweg J, Gregor M, et al. Quality-adjusted survival a- nalysis shows differences in outcome after immunosuppression or bone marrow transplantation in aplastic anemia[ J]. Ann Hematol, 2005,84( 1 ) :47-55.
  • 6Ohara A, Kojima S, Hamajima N, et al. Myelodysplastic syndrome and acute myelogenous leukemia as alate clonal complication in chil- dren with acquired aplastic anemia[ J ]. Blood, 1997,90 ( 3 ) : 1009- 1013.
  • 7Speck B, Comu P, Jeannet M, et al. Autologous marrow recovery following allogeneic marrow transplantation in a patient with severe aplastic anemial J]. Exp Hematol, 1976,4(3 ) : 131-137.
  • 8Sensenhrenner LL, Steele AA, Santos SW. Recovery of hematologic competence without engraft-menet following attempted bone marrowtransplantation for aplastic anemia: report of a case with diffusion chamber studies [ J ]. Exp Hematol, 1977,5 ( 1 ) :51-58.
  • 9Territo MC. Autologous bone marrow repopulation following high dose cyclophosphamide and allogeneic marrow transplantation in aplastic anemia[J]. Br J Haematology, 1977,36(3) :305-312.
  • 10Baran DT, Griner PF, Klemperer MR. Recovery from aplastic ane- mia after treatment with cyclophosphamide [ J ]. N Engl J Med, 1976,295 (27) : 1522-1523.

二级参考文献34

  • 1林果为.急性再生障碍性贫血40例临床分析[J].中华血液学杂志,1981,2(5):275-276.
  • 2邵宗鸿.再生障碍性贫血(再障)基础与临床.全国血液血管基础与临床学术研讨会资料汇编[M].,1997.42-44.
  • 3Dokal I, Vulliamy T. Inherited aplaslic anaemias/5one marrow failure syndromes. Blood Rev, 2008,22:141.
  • 4Young NS, Calado RT, Scheinberg P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood,2006, 108:2509.
  • 5Camitta BM, Thomas ED, Nathan DG, et al. Severe aplastic anaemia; a prospective study of the effect of early marrow trans- plantation on acute mortality. Blood,1976, 48:63.
  • 6Brodsky RA, Jones RJ. Aplastic anaemia. Lancet, 2005, 365: 1647.
  • 7Socie G, Henry-Amar M, Bacigalupo A, et al. Malignant tumors occuring after treatment of aplastic anemia. N Engl J Med, 1993,329:1152.
  • 8Kahl C, Leisenring W, Deeg HJ et al. Cyclophosphamide and antithymocyteglobulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anemia: a long-termfollow up. Br J Haematol, 2005,130: 747.
  • 9Champlin RE, Perez WS, Passweg JR et al. Bone marrow trans plantation for severe aplastic anemia: a randomized, controlled study of condition ing regimens. Blood, 2007,109: 4582.
  • 10Locasciulli A, Oneto R, Bacigalupo A et al. Outcome of patients with acquired ap]astic anemia given first line bone marrow trans plantation or immunosuppressive treatment in the last decade :a report from the European Group for Blood and Marrow Trans- plantation (EBMT). Haematologica, 2007,92 : 11.

共引文献12

同被引文献12

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部